Inactive Instrument
CTT Pharmaceutical Holdings, Inc. Share Price Other OTC
Stocks
CTTH
US12651E1064
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 32.85L 29.18L 27.24L 24.83L 46.82L 32Cr 47.26L 3.3Cr 1.28Cr 16Cr 1.23Cr 1.21Cr 52Cr | P/E 2024 |
-11.9x | P/E 2025 | -22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 32.88L 29.22L 27.27L 24.85L 46.87L 32Cr 47.31L 3.3Cr 1.28Cr 16Cr 1.23Cr 1.21Cr 52Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
50.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -22.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryan Khouri
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Greenspoon
BRD | Director/Board Member | 71 | 09/09/2014 |
Ryan Khouri
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -22.52% | -0.09% | - | - | 32.85L | ||
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | ||
| +0.25% | -3.24% | +20.21% | +79.17% | 5.74TCr | ||
| +1.66% | -1.64% | +3.12% | +36.84% | 4.76TCr | ||
| -0.36% | +2.53% | +344.05% | +718.84% | 4.43TCr | ||
| +0.96% | -3.72% | +27.23% | +31.86% | 4.25TCr | ||
| +0.92% | -1.70% | +4.71% | +111.38% | 4.07TCr | ||
| -0.54% | +2.93% | +9.31% | +54.06% | 3.1TCr | ||
| +1.56% | +3.75% | +31.90% | +29.14% | 2.85TCr | ||
| -0.58% | -3.01% | -8.62% | -12.52% | 2.43TCr | ||
| Average | -1.45% | -0.59% | +53.48% | +127.00% | 4.34TCr | |
| Weighted average by Cap. | +1.22% | -0.84% | +57.73% | +136.25% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -3L -2L -2L -2L -4L -2.41Cr -4L -25.11L -10L -1.23Cr -9L -9L -3.95Cr | -2L -1L -1L -1L -2L -1.5Cr -2L -15.65L -6L -76.62L -6L -6L -2.46Cr |
| Net Debt | 16.82T 14.94T 13.95T 12.71T 23.98T 16.17L 24.2T 2L 65.41T 8L 63.15T 61.78T 26.53L | 3.46T 3.07T 2.87T 2.61T 4.93T 3L 4.97T 34.67T 13.44T 2L 12.97T 12.69T 5L |
Employees
-
















